CareDx, Inc (NASDAQ: CDNA) is a Healthcare company (Medical - Diagnostics & Research) with a market capitalization of $3.9B. The Maz Rating grades it against the other companies in its sector.
CareDx, Inc's current Maz Rating and its five factor grades are for members: log in to see them.
At $74.56, CareDx, Inc trades at 29.5x trailing earnings, 7.8x sales and 8.2x book value, with an EV/EBITDA of 129.0. Over the last twelve months it generated about $504M of revenue and $133M of net income. It runs a gross margin of 71.0%, an operating margin of 0.8% and a net margin of 25.9%. It shows return on equity of 34.1%, return on invested capital of 0.8% and a free cash flow yield of 1.5%. On the balance sheet: a debt-to-equity ratio of 0.06 and a current ratio of 2.31. Over the past 52 weeks the share price ranged from $15.22 to $90.87, with a beta of 2.49.
CareDx, Inc does not currently pay a dividend.
14 Wall Street analyst ratings cover the stock: 11 Buy and 3 Hold, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.